Association of CALHM1 Gene Polymorphism with Late Onset Alzheimer's Disease in Iranian Population

Alzheimer's disease (AD) is a genetically heterogeneous neurodegenerative disease and Late-Onset type (LOAD) is the most common form of dementia affecting people over 65 years old. CALHM1 (P86L) encodes a transmembrane glycoprotein that controls cytosolic Ca2+ concentrations and Aβ levels and P86L polymorphism in this gene is significantly associated with LOAD in independent case controls in a number of studies. This study was performed to determine whether this polymorphism contributes to the risk for LOAD in Iranian population. One hundred and forty one AD patients and 141 healthy controls were recruited in this study. After extraction of genomic DNA, the genotype and allele frequencies were determined in case and control subjects using PCR/RFLP method. The statistical analysis showed a significant difference in the heterozygote genotype frequency in case and control groups and polymorphic allele had a protective role between two groups. Also after stratifying the subjects by their APOE-ɛ4 status, no significant association was observed. Our study suggests that P86L polymorphism could be a protective factor for late-onset Alzheimer's disease (LOAD) in Iranian population. However, to confirm these results, further study with a bigger sample size may be required.

• Publication year

  2010

• Venue

  Avicenna journal of medical biotechnology

• Publication date

  2010-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 23408664PMCID 3558160
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CALHM1 variant is not associated with Alzheimer's disease among Asians.

  2011cited by this paper
• Association between Alzheimer’s Disease and Apolipoprotein E Polymorphisms

  2010cited by this paper
• Genome-wide analysis of genetic loci associated with Alzheimer disease.

  2010cited by this paper
• The P86L common allele of CALHM1 does not influence risk for Alzheimer disease in Japanese cohorts

  2010cited by this paper
• Lack of Implication for CALHM1 P86L Common Variation in Italian Patients with Early and Late Onset Alzheimer's Disease

  2010cited by this paper
• CALHM1 P86L Polymorphism is Associated with Late-Onset Alzheimer's Disease in a Recessive Model

  2010cited by this paper
• CALHM1 P86L Polymorphism is a Risk Factor for Alzheimer's Disease in the Chinese Population

  2010cited by this paper
• No association between CALHM1 variation and risk of Alzheimer disease

  2009cited by this paper
• Alzheimer disease: Alzheimer disease neuropathology in the oldest old

  2009cited by this paper
• CALHM1 Polymorphism is not Associated with Late‐onset Alzheimer Disease

  2009cited by this paper
• A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk.

  2008cited by this paper
• No association between CALHM1 and Alzheimer's disease risk.

  2008cited by this paper
• [A proposal for diagnostic and clinical assessment criteria for Alzheimer's disease].

  2005cited by this paper
• The role of inflammation in Alzheimer's disease.

  2005cited by this paper
• Molecular genetics of Alzheimer’s disease

  2004cited by this paper
• Evidence for genetic linkage of Alzheimer's disease to chromosome 10q.

  2000cited by this paper
• Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

  1993cited by this paper

• Calcium homeostasis modulator 1 ( CALHM1 ) polymorphisms in cattle

  2017cites this paper
• Oligodendrocytes and Alzheimer's disease

  2016cites this paper
• Genetic association of CALHM1 rs2986017 polymorphism with risk of Alzheimer’s disease: a meta-analysis

  2016cites this paper
• Calcium homeostasis modulator 1 gene P86L polymorphism and the risk for alzheimer's disease: A meta-analysis.

  2016cites this paper
• Astrocytes as new targets to improve cognitive functions.

  2016cites this paper
• Modelling and investigation of NMDAR-mediated calcium signalling at Hippocampal Dendritic Spine in Alzheimer’s disease

  2016cites this paper
• Ca2+ dysregulation in the endoplasmic reticulum related to Alzheimer's disease: A review on experimental progress and computational modeling

  2015cites this paper
• Association of CALHM1 gene polymorphism with late-onset Alzheimer disease

  2013cites this paper
• Investigation of five polymorphic DNA markers associated with late onset Alzheimer disease

  2013cites this paper